EMA Panel Backs Netarsudil for Elevated Intraocular Pressure EMA Panel Backs Netarsudil for Elevated Intraocular Pressure

An EMA advisory panel recommended marketing authorization for netarsudil ophthalmic solution 0.02% for the treatment of adults with glaucoma or ocular hypertension.International Approvals
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Ophthalmology News Alert Source Type: news